登录免费注册

Aurobindo Pharma

✓ 已认证供应商

Hyderabad, India · 出口市场: US,EU,WHO

No reviews yet

认证于 2026年8月9日

产品

3

生产基地

1

Aurobindo Pharma operates GMP-certified manufacturing facilities producing APIs and intermediates for regulated markets.

★ 评价 (0)

Regulatory history

No regulatory action on record

Sourced from openFDA and the EudraGMDP register — not self-declared by the supplier.

Nothing on record for this organisation.

Performance on PharmaLink

1 of 9 metrics have enough data

On-time delivery

Not enough data

No completed orders yet

Response rate

Not enough data

No inquiries yet

Answered within 24h

Not enough data

No answered inquiries yet

Quote win rate

Not enough data

No quotes submitted yet

Dispute rate

Not enough data

No completed orders yet

Repeat buyer rate

Not enough data

No buyers yet

Completed orders

0

On PharmaLink

Average order value

Not enough data

No completed orders yet

Time on PharmaLink

2m

Joined 2026-08-09

These measure activity on PharmaLink only, not the supplier’s whole business. Rates are withheld below five samples — one delivery on time is one delivery, not a 100% record.

Commercial terms

Incoterms offered
CIF · CPT · DAP · EXW · FCA · FOB · FOB Hyderabad
Payment terms
30% advance, 70% against BL
Standard lead time
2–3 weeks
Lowest minimum order
5 kgAcross live listings; per-product MOQ may be higher.
Samples
Not offered
Cold chain
ambient

Terms are supplier-stated defaults. The binding terms are the ones on a quote you accept.

认证证书

认证证书StatusExpirySource
US FDA GMP✓2028年9月FDA drug database
CDSCO✓2028年3月CDSCO portal
Manufacturing licence (Form 25/28)✓2029年8月State FDA register

生产基地

厂址FDA FEI 编号GMP 状态最近一次检查产能
Hyderabad Unit-1Hyderabad, India · manufacturing3004123991
—
——

产品

评价No reviews yet

暂无评价。曾向该供应商采购的已认证买家可发表评价。